Based on the adoptive transfer study and the fact that CCR2-deficient mice show reduced circulating monocyte counts, it can be suggested that the beneficial effect on atherosclerosis is due to its effects on monocyte release from the bone marrow, rather than directs effects on monocyte recruitment (71, 72). Here, CCR2 is linked to atherosclerosis.